Key facts
- Notable investors include Tech Incubator Program for Startup, CNT Tech, COMEUP STARS, Next Dream Angel Club, POSTECH Holdings.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Fortel My Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Fortel My Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fortel My Health
Developer of a blood-based AI ovarian cancer diagnosis device designed to overcome the limitations in the early diagnosis of ovarian cancer. The company's device contains platelet-derived RNA analysis capabilities and AI cancer diagnosis algorithm to simultaneously screen for early ovarian cancer and endometrial cancer, helps to treat early-stage cancer that could not be detected by existing screening methods by easily, quickly, and accurately, enabling healthcare professionals to determine the presence or absence of early-stage cancer and provide treatment.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2022
- Employees
- 15
- Website
- foretell.bio/
- Ownership
- Privately Held (backing)
Fortel My Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fortel My Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fortel My Health in its N-PORT filings yet. We sweep new filings monthly.